Inhibitor of growth tumor suppressors in cancer progression

Cell Mol Life Sci. 2010 Jun;67(12):1987-99. doi: 10.1007/s00018-010-0312-z. Epub 2010 Mar 2.

Abstract

The inhibitor of growth (ING) family of tumor suppressors has five members and is implicated in the control of apoptosis, senescence, DNA repair, and cancer progression. However, little is known about ING activity in the regulation of cancer progression. ING members and splice variants seem to behave differently with respect to cancer invasion and metastasis. Interaction with histone trimethylated at lysine 4 (H3K4me3), hypoxia inducible factor-1 (HIF-1), p53, and nuclear factor kappa-B (NF-kappaB) are potential mechanisms by which ING members exert effects on invasion and metastasis. Subcellular mislocalization, rapid protein degradation, and to a lesser extent ING gene mutation are among the mechanisms responsible for inappropriate ING levels in cancer cells. The aim of this review is to summarize the different roles of ING family tumor suppressors in cancer progression and the molecular mechanisms involved.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Apoptosis / genetics
  • Apoptosis / physiology*
  • DNA Repair
  • Growth / genetics
  • Growth Inhibitors / genetics
  • Growth Inhibitors / physiology*
  • Histones / genetics
  • Histones / metabolism*
  • Humans
  • Mutation
  • NF-kappa B / genetics
  • NF-kappa B / metabolism*
  • Neoplasms / genetics
  • Neoplastic Processes
  • Tumor Suppressor Protein p53 / genetics*
  • Tumor Suppressor Protein p53 / metabolism

Substances

  • Growth Inhibitors
  • Histones
  • NF-kappa B
  • Tumor Suppressor Protein p53